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Introduction
In the last few years, the incidence of cutaneous 
infections caused by nontuberculous mycobacteria 
(NTB) is increasing owing to a high prevalence of 
immunosuppressed patients and invasive procedures 
common in the general population (mesotherapy, 
tattoo, manicure, surgery, injections, and insulin 
pumps). Since Mycobacterium immunogenum 
was described in 2001, few case reports have been 
reported, all of them in the American continent. We 
present a case of cutaneous infection caused by this 
newly discovered NTB in Europe.
Case Synopsis
A 65-year-old healthy Spanish woman presented with 
a 3-month history of pruritic lesions on abdomen. 
She was allergic to penicillin, procaine, tetracyclines, 
and streptomycin. She suffered from depression, 
hypertension, and hypercholesterolemia and was 
currently under therapy with lexapro, trankimazin, 
Abstract
In the last few years, the incidence of cutaneous 
infections caused by nontuberculous mycobacteria is 
increasing. Since Mycobacterium immunogenum was 
first described in 2001, few case reports have been 
described, all of them in the American continent. We 
report a case with cutaneous infection caused by this 
newly discovered NTB in Europe.
A 65-year-old woman presented with a 3-months 
history of pruritic lesions on abdomen. Examination 
revealed erythematous inflammatory papules, 
pustules, and crusts. Three weeks later, mycobacteria 
were cultured from the biopsy specimen. 
Mycobacterium immunogenum was identified based 
on susceptibility test results and polymerase chain 
reaction (PCR) restriction enzyme analysis. Treatment 
with clarithromycin was started. M. immunogenum 
is a nontuberculous mycobacterium that was first 
described by Wilson et al. in 2001 as a rapidly growing 
variety and new species in the Mycobacterium 
chelonae-Mycobacterium abscessus group. PCR-
restriction analysis of a 439-bp segment of the hsp65 
gene and/or sequencing the species-specific region 
of the 16S rDNA can confirm this new species. Since 
the description of M. immunogenum, 8 clinical 
case reports have been published, most involving 
cutaneous infections and all of them in the American 
continent. We present a case of cutaneous infection 
caused by M. immunogenum in a Spanish woman.
Figure 1. Erythematous inflammatory papules, pustules and 
crust in different stages of evolution involving abdomen.
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atorvastatin, and antihypertensive drugs. 
Examination revealed erythematous inflammatory 
papules, pustules, and crusts in different stages of 
evolution distributed on her abdomen and lateral 
trunk (Figure 1). We performed three skin biopsies, 
which demonstrated a subcorneal sterile pustule and 
lymphoplasmacytic inflammatory infiltrate (Figure 
2a) with non-necrotizing granulomas (Figure 2b). 
A bacterial and fungical culture from a pustule 
showed normal skin flora. A general blood test, 
chest radiography, and an abdominal ultrasound 
showed no abnormalities. Our patient was first 
treated with topical betamethasone and fusidic acid 
with a 10-day period of systemic corticosteroids 
without improvement. After incubation for 3 
weeks, mycobacteria were cultured in the biopsy 
specimen. M. immunogenum was identified based 
on susceptibility test results and polymerase chain 
reaction (PCR) restriction enzyme analysis. Treatment 
with clarithromycin was started based on antibiotic 
susceptibility. Our patient has finished her sixth 
month of clarithromycin and all the lesions have 
resolved without adverse effects.
Case Discussion
Nontuberculous mycobacteria, especially rapidly 
growing mycobacteria (RGM), are environmental 
organisms found in water, soil, dust, and aerosols, 
which can form biofilms and are resistant to standard 
disinfectants. In most cases, cutaneous infections 
result from dermatological or plastic surgery 
procedures, abscesses at injection sites, or contact 
with contaminated water [1]. M. immunogenum is an 
NTB that was first described by Wilson et al. in 2001 
as RGM and a new species in the Mycobacterium 
chelonae-Mycobacterium abscessus group [2]. It 
has been frequently recovered from metal-working 
fluids and implicated in cases of hypersensitivity 
pneumonitis among metal workers [3]. Owing to 
the lack of molecular identification methods before 
2001, probably M. immunogenum had previously 
been identified phenotypically as M. chelonae or 
M. abscessus. PCR-restriction analysis of a 439-bp 
segment of the hsp65 gene and/or sequencing the 
species-specific region of the 16S rDNA can now 
confirm this new species [3].
Since the initial description of M. immunogenum, 8 
clinical case reports have been published describing 
infection with this organism, most describing 
cutaneous infections (Table 1). To date, 25 patients 
with M immunogenum confirmed infection have 
been described. The first 11 patients correspond 
to the discovery of the mycobacterium species. In 
these cases, the clinical isolation was performed 
in urine and corneal samples, skin biopsies, joint 
fluid, or bronchoalveolar lavage fluid. No other data 
from these isolations are known. After that, 14 new 
patients have been reported with M. immunogenum 
infection. Most of them are young people with neither 
comorbidities nor immunosuppression. However, 
Shedd et al. described 2 cases of skin lesions identified 
Figure 2. A) Subcorneal sterile pustule and lymphoplasmacytic inflammatory infiltrate, H&E, 40×. B) A non-necrotizing granuloma, H&E, 
40×.
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Table 1. Characteristic of patients with Mycobacterium immunogenum infection.
Year Nº cases Country
Clinical 
specimen
Clinical 
presentation IS Enviromental source
Wilson et al. 
[1] 2001 11 USA
Clinical specimen 
and fluids
Skin, cornea, 
urine, blood, joint 
fluid
Yes/No Metal-working /fluids
Loots et al. 
[4] 2005 1 Guatemala Skin biopsy Leg ulcer No Contaminated water
Sampaio et 
al. 2006 5 Brazil Corneal scraping
Keratitis post 
LASIK Unknown
Contaminated material 
(Surgical material)
Del-Castillo 
et al. [5] 2009 3 Argentina Skin biopsy
Mesotherapy site 
injections Unknown
Contaminated material 
(Injectable mesotherapy 
solutions)
Shedd et al. 
[6] 2010 2 USA
Skin biopsy/ 
drainage
Surgical wound/ 
leg plaque
No/
multiple 
myeloma
Contaminated material 
(Razor blade/Surgical 
material)
Mitchel et 
al. [7] 2011 1 USA Skin biopsy Infected tattoo No
Contaminated material 
(Tatto reservoir)
Biggs et al. 
[3] 2012 1 USA Blood
Leg ulcers, fever, 
hypotension 
Renal 
transplant Unknown
G re n i n g e r 
et al. [10] 2015 1 USA Cerebral abscess
Headache, fever, 
visual impairment No Contaminated water
G a r c í a -
Zamora et 
al.
2016 1 Spain Skin biopsy Abdominal pap-ules and pustules No Unknown
IS: immunosuppression
by 16S rRNA gene sequencing, one of which involved 
an elderly man with multiple myeloma treated with 
dexamethasone and IL-6 inhibitor [6].
More than 50% of patients presented with 1-3 
months history of persistent cutaneous papules, 
nodules, or plaques with evolution despite treatment 
with topical corticosteroids and several antibiotic 
systemic cycles. Neither fever nor chills nor general 
discomfort was noted with the exception of the first 
case of disseminated M. immunogenum infection 
reported by Biggs et al., which involved a 59-year-
old man with renal transplant presenting with septic 
shock and skin lesions [1, 7]. In most cases, some 
invasive procedure of the skin had been performed 
in the previous weeks or months. Del-Castillo et al. 
described 28 cases of skin lesions after mesotherapy 
[5]; PCR-restriction analysis of hsp65 gene identified 
M. immunogenum in three of ten biopsy samples, 
and Mitchell at al. described cutaneous lesions at the 
site of a recent tattoo [7].
Once the diagnosis was made, all patients described 
received antibiotic treatment based on antibiotic 
susceptibilities. Most were treated with clarithromycin 
plus other antibiotic (levofloxacin or ciprofloxacin) 
or amikacin over approximately 6 months without 
complications and with complete resolution of the 
lesions.
Optimal treatment for M. immunogenum remains 
unknown. Retrospective studies of cutaneous NTM 
infections recommended the use of clarithromycin 
because of excellent in vitro susceptibility as well 
as clinical response [8]. Treatment of disseminated 
cutaneous infection with an organism in the M. 
chelonae-M. abscessus group should last at least 6 
months and consist of clarithromycin plus additional 
agents, given the risk of clarithromycin resistance 
with monotheraphy (estimated 10-20%), [9].
Conclusion
We present a new case of cutaneous infection 
caused by M. immunogenum in Europe in 
an immunocompetent Spanish woman with 
erythematous inflammatory papules and pustules 
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on the abdomen. No invasive or esthetic procedures 
were performed in our patient and we could not 
discover any possible source of infection.
References
1. Biggs HM, Chudgar SM, Pfeiffer CD, Rice KR et al. Disseminated 
Mycobacterium immunogenum infection presenting with septic 
shock and skin lesions in a renal transplant recipient. Transpl Infect 
Dis 2012; 14: 415-421. [PMID: 22548769].
2. Wilson RW, Steingrube VA, Bottger EC, et al. Mycobacterium 
immunogenum sp. nov., a novel species related to Mycobacterium 
abscessus and associated with clinical disease, pseudo-outbreaks 
and contaminated metalworking fluids: an international 
cooperative study on mycobacterial taxonomy. Int J Syst Evol 
Microbiol 2001; 51 (Pt 5): 1751-1764. [PMID: 11594606].
3. Wallace RJ Jr, Zhang Y, Wilson RW, Mann L et al. Presence of a 
single genotype of the newly described specie Mycobacterium 
immunogenum in industrial metalworking fluids associated 
with hypersensitivity pneumonitis. Appl Environ Microbiol. 2002 
Nov;68(11):5580-4. [PMID: 129929].
4. Loots MA, de Jong MD, van Soolingen D, Wetsteyn JC, Faber WR. 
Chronic leg ulcer caused by Mycobacterium immunogenum. J 
Travel Med 2005;12 (6): 347-349. [PMID: 16343388].
5. Del-Castillo M, Palmero D, Lopez B, et al. Mesotherapy-associated 
outbreak caused by Mycobacterium immunogenum. Emerg Infect 
Dis 2009; 15 (2): 357-359. [PMID: 19193300].
6. Shedd AD, Edhegard KD 2nd, Lugo-Somolinos A. Mycobacterium 
immunogenum skin infections: two different presentations. Int J 
Dermatol 2010; 49 (8): 941-944. [PMID: 21128921].
7. Mitchell CB, Isenstein A, Burkhart CN, Groben P, Morrell DS. Infection 
with Mycobacterium immunogenum following a tattoo. J Am Acad 
Dermatol 2011; 64 (5): e70-e71. [PMID: 21496684].
8. Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous 
mycobacterial infections of the skin: a retrospective study of 25 
cases. J Am Acad Dermatol 2007; 57: 413-420. [PMID: 17368631].
9. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of 
pathogenic nonpigmented or late-pigmenting rapidly growing 
mycobacteria. Clin Microbiol Rev 2002; 15 (4): 716-746. [PMID: 
12634376].
10. Greninger AL, Langelier C, Cunningham G, Keh C et al. Two rapidly 
growing mycobacterial species isolated from a brain abscess: first 
whole-genome sequences of Mycobacterium immunogenum and 
Mycobacterium Ilatzerense. J Clin Microbiol 2015; 53 (7): 2374-2377. 
[PMID: 25926490].
